VNDA VNDA

Vanda Pharmaceuticals Stock Price

9.53
-0.14 (-1.45%)
Upgrade to Real-Time
Afterhours (Closed)
9.53
Volume 308,502
Bid Price 8.83
Ask Price 10.06
News -
Day High 9.80

Low
9.24

52 Week Range

High
21.4399

Day Low 9.50
Company Name Stock Ticker Symbol Market Type
Vanda Pharmaceuticals Inc VNDA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.14 -1.45% 9.53 16:23:55
Open Price Low Price High Price Close Price Prev Close
9.60 9.50 9.80 9.53 9.67
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,579 308,502 $ 9.61 $ 2,965,990 - 9.24 - 21.4399
Last Trade Time Type Quantity Stock Price Currency
16:30:22 priorref 552 $ 9.53 USD

Period:

Draw Mode:

Vanda Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 539.03M 56.56M 45.30M $ 268.68M $ 11.20M 0.58 48.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 117.07k 5.20%

more financials information »

Vanda Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VNDA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week9.9510.029.459.75367,980-0.42-4.22%
1 Month10.1511.059.4510.21431,321-0.62-6.11%
3 Months11.1211.909.4510.61386,229-1.59-14.3%
6 Months11.4912.349.2410.50479,594-1.96-17.06%
1 Year17.4021.43999.2412.94498,475-7.87-45.23%
3 Years13.9421.86277.1213.49529,751-4.41-31.64%
5 Years18.6033.447.1215.81590,929-9.07-48.76%

Vanda Pharmaceuticals Description

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765.


Your Recent History
NASDAQ
VNDA
Vanda Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now